Efficacy of radium-223 in bone-metastatic castration-resistant prostate cancer with and without homologous repair gene defects

European Urology Jul 16, 2019

Velho PI, et al. - Through a retrospective single-institution stud of 190 metastatic castrate-resistant prostate cancer (mCRPC) subjects for whom germline and/or somatic DNA sequencing data were available, the researchers assessed the potential influence of germline or somatic HR-deficiency (HRD) mutations on radium-223 (a bone-seeking α-emitter that induces double-strand DNA breaks, thereby killing cancer cells in the bone microenvironment) efficiency in mCRPC with bone metastasis. Out of 190, 28 received standard-of-care radium-223 at Johns Hopkins between February 2013 and February 2018, out of which 10 men had a germline/somatic HRD mutation and 18 men did not. Men with HRD mutations (HRD+) had numerically lower ages, more soft-tissue metastases, and greater baseline ALP levels. HRD(+) patients exhibited greater alkaline phosphatase (ALP) responses more prolonged time to ALP progression and a trend toward longer overall survival, in comparison with HRD(–) men. Among the two groups, prostate-specific antigen responses and time to next systemic therapy were similar. Hence, bone-metastatic CRPC subjects with inactivating HRD mutations exhibited markedly enhanced ALP responses and time to ALP progression. Moreover, among HRD mutations and radium-223 activity, these results should prompt prospective validation of the “synthetic lethality” hypothesis.
Full text available Go to Original

Sign-up to continue reading. It is free & takes less than 2 mins

  • 45 lakhs+ doctors trust M3 globally

  • Nonloggedininfinity icon
    Free & unlimited access to original articles and quizzes
  • Nonloggedinlock icon
    Secure: we never sell your data
This article is only available to members. Are you a doctor? Click here to signup for free.
M3 app logo
Choose easy access to M3 India from your mobile!

M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen